Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
272.20    4.00 (1.49%)
Bid:
271.10
Ask:
271.30
Spread: 0.20 (0.074%)
Market Cap: £14.94b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Directorate Change

7 Mar 2022 07:00

RNS Number : 7766D
Legal & General Group Plc
07 March 2022
 

Legal & General Group Plc Board announces the appointment of Tushar Morzaria as a non-executive director of Legal & General Group Plc

 

7 March 2022

 

The Board of Legal & General Group Plc (the "Company") is pleased to announce the appointment of Tushar Morzaria as an independent non-executive director of the Company with effect from 27 May 2022. Tushar will join as Chair of the Group Audit Committee upon appointment and will also join the Group Risk Committee, the Group Remuneration Committee and Group Nominations and Corporate Governance Committee.

 

Mr Morzaria has extensive financial services experience, including eight years as the Group Finance Director of Barclays PLC and, prior to that, as the Chief Financial Officer of Global Investment Banking at JP Morgan Chase & Co. Mr Morzaria will retire from his position at Barclays PLC prior to joining the Company.

 

The Board further wishes to announce that following his recent appointment as the Chair of Age UK, Toby Strauss has decided to step down as a non-executive director of the Company with effect from 29 April 2022 after more than five years of service. Sir John Kingman will assume the role as the Chair of the Group Risk Committee on a temporary basis upon Toby's departure pending the appointment of his successor.

 

Sir John Kingman, Group Chairman, said:

 

"I am delighted to welcome Tushar to the Group Board. He brings with him a wealth of expertise in financial services and transformation. I very much look forward to working with Tushar and welcoming him to the Board in May. I would like to thank Philip Broadley for his outstanding stewardship of the Group Audit Committee over the past six years and for his continuing counsel in his role as Senior Independent Director.

 

I would also like to take this opportunity to thank Toby for his significant contributions to the Board during his tenure. It has been a great pleasure to work alongside Toby and we wish him all the best for the future."

 

Mr Morzaria is currently a non-executive director of BP plc and the chair of its audit committee. There are no details or disclosures required under LR 9.6.13R of the Financial Conduct Authority's Listing Rules.

 

 

 

Notes to Editors

Legal & General Group Plc

 

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with over £1.3 trillion in total assets under management of which a third is international. L&G also provides powerful asset origination capabilities. Together, these underpin our leading retirement and protection solutions: we are a leading international player in pension risk transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. As at 4 March 2022, Legal & General has a market capitalisation of £14.55 billion.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGGFRVVGZZM
Date   Source Headline
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSAdmission to Trading
1st Jun 20266:15 pmRNSTotal Voting Rights
1st Jun 20266:15 pmRNSTransaction in Own Shares
26th May 20266:15 pmRNSTransaction in Own Shares
26th May 20269:00 amRNSOutcome of Audit Tender
21st May 20264:15 pmRNSResult of AGM and GM
20th May 20266:15 pmRNSDirector/PDMR Shareholding
18th May 20266:15 pmRNSTransaction in Own Shares
11th May 20266:15 pmRNSTransaction in Own Shares
5th May 20266:15 pmRNSDirector/PDMR Shareholding
5th May 20266:15 pmRNSTransaction in Own Shares
5th May 202612:15 pmRNSHolding(s) in Company
1st May 20266:15 pmRNSDirector/PDMR Shareholding
1st May 20266:15 pmRNSTotal Voting Rights
1st May 20266:15 pmRNSAdmission to Trading
1st May 20266:15 pmRNSDirector/PDMR Shareholding
28th Apr 20266:15 pmRNSDirector/PDMR Shareholding
27th Apr 20266:15 pmRNSTransaction in Own Shares
21st Apr 20266:15 pmRNSDirector/PDMR Shareholding
20th Apr 20266:15 pmRNSTransaction in Own Shares
13th Apr 20266:15 pmRNSTransaction in Own Shares
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
9th Apr 202610:00 amRNSNotice of 2026 AGM and GM
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
7th Apr 20266:15 pmRNSTransaction in Own Shares
1st Apr 20266:15 pmRNSAdmission to Trading
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSTotal Voting Rights
1st Apr 20261:30 pmRNSPublication of a Prospectus
30th Mar 20266:15 pmRNSTransaction in Own Shares
26th Mar 20266:15 pmRNSDirector/PDMR Shareholding
24th Mar 20266:15 pmRNSDirector/PDMR Shareholding
20th Mar 20266:15 pmRNSDirector/PDMR Shareholding
18th Mar 20266:15 pmRNSDirector/PDMR Shareholding
18th Mar 202612:00 pmRNSAnnual Financial Report
16th Mar 20266:15 pmRNSTransaction in Own Shares
16th Mar 20266:15 pmRNSDirectorate change
13th Mar 20266:15 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSCommencement of Share Buyback
11th Mar 20267:00 amRNSL&G Full Year Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.